#413: Budgeting Blind Spots: What MedTech Startups Miss—and How Investors See It

Global Medical Device Podcast · 30 Jun 2025 · 35m · Episode 413

What this episode covers

Jon Bergsteinsson, founder of Smart Trial (acquired by Greenlight Guru) and investor at Leaf Ventures and Iceband, explains why early-stage MedTech startups frequently overlook budgeting for regulatory, clinical, and quality operations. He details how inexperienced founders lump compliance costs into single line items, ignoring essential software licenses (eQMS, CAD), testing fees, and post-market surveillance, which raises red flags for investors. Bergsteinsson advises founders to break out specific cost categories, use AI and networking to scout market rates, and build best/worst-case scenarios to avoid financial risk and ensure product quality.

Other shows on the same ground, closest first.

  • Being an Engineer · 46m

    S5E8 Aaron Call | How to Find Money for MedTech Startups

    Aaron Call, founding principal of Jaunt, explains how his company helps MedTech startups navigate market intelligence and fundraising by focusing on customer discovery rather than just technical feasibility. He distinguishes between sustaining and disruptive innovation, detailing how Jaunt uses qualitative and quantitative research to validate product-market fit for Class I and II devices. Call also outlines the current venture capital landscape, noting the shift toward funding only exceptional companies, and discusses the integration of AI in healthcare administration and device development.

  • Let's Combinate · 21m

    216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

    Stephen O'Rourke, founder of the consultancy Clarifi, discusses regulatory strategy for MedTech, biotech, and novel food startups navigating EU and US pathways. He highlights the hidden costs of regulatory failure, emphasizing the need for early engagement with agencies and the importance of UDI compliance across all departments. O'Rourke also explores emerging regulatory models in the UAE and Singapore, explaining how regulatory sandboxes and national initiatives are accelerating innovation, and shares insights from his run for the European Parliament on how policy is made.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

  • Being an Engineer · 57m

    S6E35 Spencer Jones | AI for Engineers, Finding Venture Capital, & Accelerating Medtech Development

    Spencer Jones, CEO of Lapovations and founder of XO Medtech, discusses his journey from registered nurse to serial medtech entrepreneur, highlighting the development of SafeBreak Vascular and AbGrab. He details the critical role of accelerators in securing early 'dirt money' and provides strategic advice on navigating venture capital fundraising, emphasizing the importance of warm intros and comprehensive data rooms. Jones also shares how he leverages AI tools like ChatGPT, Claude, and Roboflow to accelerate product development, investor outreach, and engineering workflows, while warning startups against skipping customer discovery and over-engineering prototypes.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.